Abstract| Volume 23, ISSUE 10, SUPPLEMENT , S10, October 2017

Does Device Therapy Have a Crucial Role in the Treatment of Heart Failure among Very Elderly People?

      Most of evidences for pharmacological and nonpharmacological therapy for heart failure are established in relatively younger patients. However, in our country, inhospital patients are now over 80 years old in average according to the rapid aging demographics. Especially, invasive therapy including implantable devices for heart failure needs to be discussed for the indication in terms of cost and risk and benefit in such very old patients. I will discuss in this session about the dilenmma of device therapy on cardiac resynchronization therapy, implantable cardiac defibrillator, and left ventricular assist device.
      To read this article in full you will need to make a payment

      Purchase one-time access:

      Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
      One-time access price info
      • For academic or personal research use, select 'Academic and Personal'
      • For corporate R&D use, select 'Corporate R&D Professionals'


      Subscribe to Journal of Cardiac Failure
      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Institutional Access: Sign in to ScienceDirect